Reference 2019-583

REF:            2019-583

Subject:        Intra-vitreal vials/implants

 

 

Request:

Within your trust how many of the following intra-vitreal vials/implants have been used in the latest 4 months, if possible between May to August 2019;

Ranibizumab

Bevacizumab

Aflibercept

Fluocinolone

Dexamethasone

 

 

Response:

The number of intra-vitreal vials/implants issued between May and August 2019 was:
Ranibizumab 1,062
Bevacizumab 0
Aflibercept 1,007
Fluocinolone 0
Dexamethasone 10